Skip to main content

Table 2 Odds ratio (OR) and relative risk (RR) and 95% confidence intervals (CI) for the EPO SNP rs1617640 healthy control subjects and patients with various hematologic diseases

From: Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome

 

Odds Ratio

Relative Risk

 

OR

95% CI

RR

95% CI

MDS vs. ALL

    

G/G

2.2

1.15-4.24

1.28

1.07-1.52

G/T

0.45

0.28-0.74

0.75

0.62-0.90

T/T

1.41

0.84-2.37

1.13

0.95-1.34

MDS vs. AML

    

G/G

2.36

1.44-3.88

1.55

1.24-1.94

G/T

0.79

0.54-1.16

0.87

0.70-1.09

T/T

0.75

0.56-1.10

0.84

0.67-1.06

MDS vs. CLL

    

G/G

2.62

1.29-5.33

1.31

1.11-1.54

G/T

1.19

0.71-1.98

1.06

0.89-1.25

T/T

0.48

0.29-0.80

0.77

0.64-0.93

MDS vs. CML

    

G/G

2.36

1.49-3.72

1.66

1.30-2.11

G/T

0.67

0.47-0.96

0.77

0.60-0.97

T/T

0.89

0.62-1.29

0.93

0.73-1.18

MDS vs. Normal

    

G/G

4.98

2.04-12.13

1.45

1.26-1.67

G/T

0.84

0.51-1.39

0.94

0.79-1.12

T/T

0.55

0.33-0.90

0.81

0.68-0.97

ALL vs. AML

    

G/G

1.07

0.55-2.10

1.05

0.66-1.68

G/T

1.74

1.10-2.75

1.48

1.07-2.05

T/T

0.53

0.32-0.86

0.63

0.44-0.91

ALL vs. CLL

    

G/G

1.19

0.51-2.76

1.08

0.74-1.58

G/T

2.61

1.48-4.61

1.57

1.20-2.06

T/T

0.34

0.19-0.61

0.58

0.42-0.80

ALL vs. CML

    

G/G

1.07

0.56-2.04

1.05

0.64-1.72

G/T

1.47

0.95-2.27

1.34

0.96-1.89

T/T

0.63

0.39-1.01

0.70

0.48-1.02

ALL vs. Normal

    

G/G

2.26

0.83-6.13

1.38

1.00-1.90

G/T

1.86

1.06-3.25

1.34

1.02-1.76

T/T

0.39

0.22-0.69

0.62

0.46-0.85

AML vs. CLL

    

G/G

1.11

0.54-2.30

1.03

0.85-1.24

G/T

1.50

0.92-2.44

1.11

0.98-1.26

T/T

0.65

0.41-1.04

0.89

0.78-1.01

AML vs. CML

    

G/G

1.00

0.61-1.62

1.00

0.75-1.32

G/T

0.84

0.61-1.16

0.91

0.75-1.09

T/T

1.19

0.86-1.66

1.11

0.92-1.33

AML vs. Normal

    

G/G

2.11

0.85-5.22

1.18

1.01-1.37

G/T

1.07

0.66-1.71

1.02

0.90-1.16

T/T

0.73

0.46-1.17

0.92

0.81-1.05

CLL vs. CML

    

G/G

0.90

0.44-1.81

0.92

0.52-1.61

G/T

0.56

0.35-0.90

0.63

0.44-0.92

T/T

1.84

1.17-2.90

1.61

1.13-2.29

CLL vs. Normal

    

G/G

1.90

0.67-5.36

1.32

0.90-1.93

G/T

0.71

0.40-1.27

0.84

0.62-1.14

T/T

1.13

0.64-1.99

1.06

0.80-1.41

CML vs. Normal

    

G/G

2.11

0.87-5.12

1.13

1.01-1.27

G/T

1.27

0.80-2.00

1.05

0.95-1.16

T/T

0.61

0.39-0.97

0.90

0.81-1.00

Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us